TECHNOLOGY:  

Extraction of high purity, high volume IgY antibodies from yolk.

AFFILIATION:   IGY Life Sciences USA Inc., Houston, Texas, United States

TECHNOLOGY SUMMARY

Track: Medical & Biotech
Area: Infectious Disease
Tech Readiness: TRL 3

Tech Brief: Vaccination of poultry with a human derived Universal Influenza Vaccine, which produces broad protection for people. Extraction of IgY via novel technology can produce kilogram quantities of antibodies, good for passive immunization, therapeutics and to stock pile for possible pandemic outbreak.

FIGURES OF MERIT

Value Proposition: IgY can be transformed to create antibodies toward viral or bacterial pathogens that are commonly encountered by military personal on a global basis. The military will be able to execute troops into the field in a timely basis knowing that they can protect their soldiers with antibodies toward common diseases once they arrive in the new hot spot.

SHOWCASE SUMMARY

Org Type: Commercial Startup (C+)
Booth Number: W821